Published in Am J Drug Alcohol Abuse on November 01, 2002
Motivational Interviewing to Reduce Substance Use Among Depression Patients | NCT02420561
Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence. J Psychiatr Res (2007) 2.63
Marijuana use motives and social anxiety among marijuana-using young adults. Addict Behav (2007) 2.16
Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence. J Int Neuropsychol Soc (2007) 2.05
Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol Teratol (2006) 2.01
The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev (2008) 1.78
Prediction of cannabis use disorder between boyhood and young adulthood: clarifying the phenotype and environtype. Am J Addict (2009) 1.58
fMRI response to spatial working memory in adolescents with comorbid marijuana and alcohol use disorders. Drug Alcohol Depend (2005) 1.57
Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Res (2008) 1.50
Relations between anxiety sensitivity, distress tolerance, and fear reactivity to bodily sensations to coping and conformity marijuana use motives among young adult marijuana users. Exp Clin Psychopharmacol (2009) 1.41
Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Front Psychiatry (2013) 1.34
Diffusion tensor measures of the corpus callosum in adolescents with adolescent onset alcohol use disorders. Alcohol Clin Exp Res (2008) 1.29
Amygdala FAAH and anandamide: mediating protection and recovery from stress. Trends Pharmacol Sci (2013) 1.27
Antisocial behavioral syndromes and DSM-IV drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend (2007) 1.24
Social anxiety disorder and marijuana use problems: the mediating role of marijuana effect expectancies. Depress Anxiety (2009) 1.21
Immediate antecedents of marijuana use: an analysis from ecological momentary assessment. J Behav Ther Exp Psychiatry (2011) 1.20
Gone to Pot - A Review of the Association between Cannabis and Psychosis. Front Psychiatry (2014) 1.14
Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults. Drug Alcohol Depend (2010) 1.13
Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions. Drug Alcohol Depend (2012) 1.10
A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend (2009) 1.10
Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Schizophr Res (2013) 1.10
The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users. J Psychoactive Drugs (2010) 1.10
Acute Effects of Marijuana Smoking on Negative and Positive Affect. J Cogn Psychother (2011) 1.08
Neural correlates of verbal learning in adolescent alcohol and marijuana users. Addiction (2010) 1.08
Heritability and a genome-wide linkage analysis of a Type II/B cluster construct for cannabis dependence in an American Indian community. Addict Biol (2009) 1.06
Social anxiety and cannabis use: an analysis from ecological momentary assessment. J Anxiety Disord (2011) 1.05
The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC). Drug Alcohol Depend (2012) 1.05
Anxiety sensitivity and marijuana use: an analysis from ecological momentary assessment. Depress Anxiety (2011) 1.04
PTSD contributes to teen and young adult cannabis use disorders. Addict Behav (2009) 1.03
Social anxiety and marijuana-related problems: the role of social avoidance. Addict Behav (2010) 1.02
A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research. Alcohol (2012) 1.02
The alcohol-preferring (P) and high-alcohol-drinking (HAD) rats--animal models of alcoholism. Alcohol (2013) 1.02
A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population--a meta-analysis of 31 studies. BMC Psychiatry (2014) 1.01
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addiction (2013) 1.01
Early cannabis use and estimated risk of later onset of depression spells: Epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative. Am J Epidemiol (2010) 1.00
Exploring the mediational role of coping motives for marijuana use in terms of the relation between anxiety sensitivity and marijuana dependence. Am J Addict (2010) 1.00
Chronic adolescent marijuana use as a risk factor for physical and mental health problems in young adult men. Psychol Addict Behav (2015) 1.00
Delineation of differential temporal relations between specific eating and anxiety disorders. J Psychiatr Res (2010) 0.99
Spatial working memory performance and fMRI activation interaction in abstinent adolescent marijuana users. Psychol Addict Behav (2007) 0.99
Common genetic contributions to alcohol and cannabis use and dependence symptomatology. Alcohol Clin Exp Res (2009) 0.98
Externalizing disorders in American Indians: comorbidity and a genome wide linkage analysis. Am J Med Genet B Neuropsychiatr Genet (2008) 0.98
Simultaneous alcohol and cannabis expectancies predict simultaneous use. Subst Abuse Treat Prev Policy (2006) 0.98
Generalizability of clinical trials for cannabis dependence to community samples. Drug Alcohol Depend (2010) 0.97
Daily marijuana use and suicidality: the unique impact of social anxiety. Addict Behav (2011) 0.96
Marijuana craving during a public speaking challenge: Understanding marijuana use vulnerability among women and those with social anxiety disorder. J Behav Ther Exp Psychiatry (2010) 0.95
Social anxiety and coping motives for cannabis use: The impact of experiential avoidance. Psychol Addict Behav (2013) 0.94
Uni-morbid and co-occurring marijuana and tobacco use: examination of concurrent associations with negative mood states. J Addict Dis (2010) 0.92
Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. Recent Pat CNS Drug Discov (2012) 0.91
Prevalence, patterns, and correlates of co-occurring substance use and mental disorders in the United States: variations by race/ethnicity. Compr Psychiatry (2011) 0.91
Interpreting the association between cannabis use and increased risk for schizophrenia. Dialogues Clin Neurosci (2005) 0.90
Cortical thickness in adolescent marijuana and alcohol users: A three-year prospective study from adolescence to young adulthood. Dev Cogn Neurosci (2015) 0.89
Cannabis and related impairment: the unique roles of cannabis use to cope with social anxiety and social avoidance. Am J Addict (2014) 0.88
Motivational and mindfulness intervention for young adult female marijuana users. J Subst Abuse Treat (2011) 0.88
Cannabis use behaviors and social anxiety: the roles of perceived descriptive and injunctive social norms. J Stud Alcohol Drugs (2014) 0.87
Neuropsychological performance in adolescent marijuana users with co-occurring alcohol use: A three-year longitudinal study. Neuropsychology (2015) 0.84
Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders. Child Adolesc Psychiatry Ment Health (2010) 0.83
The interactive effect of anxiety sensitivity and frequency of marijuana use in terms of anxious responding to bodily sensations among youth. Psychiatry Res (2009) 0.83
Mechanisms underlying the link between cannabis use and prospective memory. PLoS One (2012) 0.83
Marijuana's acute effects on cognitive bias for affective and marijuana cues. Exp Clin Psychopharmacol (2015) 0.82
The Dutch Cannabis Dependence (CanDep) study on the course of frequent cannabis use and dependence: objectives, methods and sample characteristics. Int J Methods Psychiatr Res (2011) 0.81
Marijuana and body weight. Innov Clin Neurosci (2014) 0.80
Cannabis use and anxiety: is stress the missing piece of the puzzle? Front Psychiatry (2014) 0.79
Anxiety sensitivity as a mediator of the relationship between moderate-intensity exercise and coping-oriented marijuana use motives. Am J Addict (2011) 0.77
Prevalence and correlates of cannabis use in an outpatient VA posttraumatic stress disorder clinic. Psychol Addict Behav (2016) 0.77
Cannabis craving in response to laboratory-induced social stress among racially diverse cannabis users: The impact of social anxiety disorder. J Psychopharmacol (2016) 0.77
Cannabis Abuse Is Increasing and Associated with Increased Emergency Department Utilization in Gastroenterology Patients. Dig Dis Sci (2016) 0.76
Solitary cannabis use frequency mediates the relationship between social anxiety and cannabis use and related problems. Am J Addict (2016) 0.76
Longitudinal associations between social anxiety symptoms and cannabis use throughout adolescence: the role of peer involvement. Eur Child Adolesc Psychiatry (2015) 0.76
The mediating roles of coping, sleep, and anxiety motives in cannabis use and problems among returning veterans with PTSD and MDD. Psychol Addict Behav (2016) 0.76
Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes. Addiction (2016) 0.75
Longitudinal influence of alcohol and marijuana use on academic performance in college students. PLoS One (2017) 0.75
Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis. Pharmaceuticals (Basel) (2010) 0.75
Cannabis and development of dual diagnoses: A literature review. Am J Drug Alcohol Abuse (2016) 0.75
TREATMENT TRIAL AND LONG-TERM FOLLOW-UP EVALUATION AMONG COMORBID YOUTH WITH MAJOR DEPRESSION AND A CANNABIS USE DISORDER. Int J Med Biol Front (2012) 0.75
Anxiety and cannabis-related problem severity among dually diagnosed outpatients: The impact of false safety behaviors. Addict Behav (2017) 0.75
The impact of marijuana use on memory in HIV-infected patients: a comprehensive review of the HIV and marijuana literatures. Curr Drug Abuse Rev (2016) 0.75
Assessing TLI as a Predictor of Treatment Seeking for SUD among Youth Transitioning to Young Adulthood. Adv Psychol Res (2013) 0.75
Personality Traits Predict the Developmental Course of Externalizing: A Four-wave Longitudinal Study Spanning Age 17 to Age 29. J Pers (2016) 0.75
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies. J Soc Clin Psychol (2015) 0.75
Structural imaging for addiction medicine: From neurostructure to neuroplasticity. Prog Brain Res (2015) 0.75
Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder. PLoS One (2016) 0.75
Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry (2002) 2.56
Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. Am J Psychiatry (2011) 2.29
Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend (2003) 2.10
Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry (2006) 1.78
Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. Am J Addict (2004) 1.46
Suicide attempts in substance abusers: effects of major depression in relation to substance use disorders. Am J Psychiatry (2002) 1.23
Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial. Trials (2011) 1.19
Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study. Am J Psychiatry (2005) 1.18
Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatment. J Subst Abuse Treat (2008) 1.15
The latent structure of marijuana and cocaine use disorders: results from the National Longitudinal Alcohol Epidemiologic Survey (NLAES). Drug Alcohol Depend (2007) 0.99
Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. J Addict Dis (2002) 0.95
Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial. J Dual Diagn (2009) 0.92
Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse. Contemp Clin Trials (2011) 0.88
Comorbid psychiatric and substance abuse disorders: recent treatment research. Subst Abus (2008) 0.87
Effects of HIV triple therapy on methadone levels. Am J Addict (2002) 0.80
Baseline characteristics of patients predicting suitability for rapid naltrexone induction. Am J Addict (2015) 0.80
A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients. Am J Addict (2013) 0.79
Temperament characteristics, as assessed by the tridimensional personality questionnaire, moderate the response to sertraline in depressed opiate-dependent methadone patients. Drug Alcohol Depend (2005) 0.78
Comparison of substance use milestones in cannabis- and cocaine-dependent patients. J Addict Dis (2012) 0.78
Effects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence. Addiction (2012) 0.77
Antisocial behavioral syndromes in cocaine and cannabis dependence. Am J Drug Alcohol Abuse (2008) 0.76
Medical and Mental Health Status Among Drug Dependent Patients Participating in a Smoking Cessation Treatment Study. J Drug Issues (2009) 0.75
Baseline characteristics of patients predicting suitability for rapid naltrexone induction. Am J Addict (2014) 0.75
Management of Opioid Use Disorder in Primary Care Settings With a Focus on Long-Acting Medication Formulations. Cutis (2021) 0.75